3-quinuclidinyl-4-iodobenzilate has been researched along with fluorodeoxyglucose f18 in 1 studies
Studies (3-quinuclidinyl-4-iodobenzilate) | Trials (3-quinuclidinyl-4-iodobenzilate) | Recent Studies (post-2010) (3-quinuclidinyl-4-iodobenzilate) | Studies (fluorodeoxyglucose f18) | Trials (fluorodeoxyglucose f18) | Recent Studies (post-2010) (fluorodeoxyglucose f18) |
---|---|---|---|---|---|
37 | 4 | 0 | 34,771 | 2,160 | 20,111 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braun, A; Chase, TN; Coppola, R; Gibson, R; Gorey, J; Jones, D; Mann, U; Reba, RC; Weinberger, DR | 1 |
1 other study(ies) available for 3-quinuclidinyl-4-iodobenzilate and fluorodeoxyglucose f18
Article | Year |
---|---|
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Models, Anatomic; Neuropsychological Tests; Quinuclidinyl Benzilate; Receptors, Cholinergic; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |